Cerity Partners’s Pfizer PFE Stock Holding History

Cerity Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.63K	Buy	+400	New	+$10.5K	﹤0.01%	3391

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cerity Partners's PFE Position: Q2 2026 in Review

Cerity Partners increased its Pfizer (PFE) stake by 7% in Q2 2026, buying an estimated $3.1M and bringing the position to 1,816,537 shares worth $43.7M. The position accounts for 0.05% of the portfolio, ranked #285.

Cerity Partners first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $79.4M in Q4 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cerity Partners held 1,816,537 shares of Pfizer worth $43.7M as of Q2 2026.
Cerity Partners bought 118,345 Pfizer shares in Q2 2026, an estimated $3.1M.
Pfizer made up 0.05% of Cerity Partners's portfolio in Q2 2026, its #285 holding.
Cerity Partners first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
Cerity Partners's Pfizer position peaked at $79.4M in Q4 2025.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.